APDN Signs Agreement with Schreiner Group to Protect Pharmaceutical Supply Chains
August 7th, 2019
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Press Release
Applied DNA Schedules Fiscal 2019 Third Quarter Financial Results Conference Call for Tuesday, August 13, 2019 at 4:30 PM ET
August 6th, 2019
Applied DNA and TheraCann International Sign Term Sheet to Amend Licensing and Cooperation Agreement
August 5th, 2019
Applied DNA Raises $1.5 Million In Secured Convertible Notes
July 17th, 2019
5-Year Agreement with Montblanc to Provide SigNature® DNA with Beacon® to Prestige Montblanc Clients
July 2nd, 2019
LineaRx Receives Multiple Orders for Linear DNA for Use in Therapeutic Development
July 1st, 2019
LineaRx to Support Therapy Development for Neurodegenerative Diseases
June 26th, 2019
TheraCann Adds Blockchain Functionality to ETCH biotrace Platform Powered by Applied DNA
June 24th, 2019
Molecular Tagging of Pharma Drugs Published in Peer-Reviewed Journal
June 14th, 2019
